Pharmerica
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pharmerica's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3% to $2,091,100,000. Profit margin reached 1%. Total operating expenses were $254,300,000.
Profit Margin
| 2013 | 1.75B | 18.9M | 1.08% |
|---|---|---|---|
| 2014 | 1.89B | 6.8M | 0.36% |
| 2015 | 2.02B | 35.1M | 1.73% |
| 2016 | 2.09B | 21.6M | 1.03% |
PMC Income Statement (2013 – 2016)
| 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 2.09B | 2.02B | 1.89B | 1.75B |
Cost of revenue | 1.76B | 1.69B | 1.55B | 1.43B |
Gross profit | 326M | 335.1M | 339.3M | 327.2M |
Operating exp. | ||||
Research and development | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 254.3M | 251.1M | 256.4M | 240.7M |
Operating income | 38.4M | 53.8M | 30.4M | 55.8M |
Other income (expenses), net | -9.5M | -6.6M | -14.2M | -10.6M |
Income before tax | 28.9M | 47.2M | 16.2M | 45.2M |
Income tax expense | 7.3M | 12.1M | 9.4M | 26.3M |
Net income | 21.6M | 35.1M | 6.8M | 18.9M |
Earnings per share | ||||
Basic EPS | 0.7 | 1.16 | 0.23 | 0.64 |
Diluted EPS | 0.69 | 1.14 | 0.22 | 0.63 |
| Data source | Data source | Data source | Data source |